Join other private equity professionals in learning how CFOs can tackle the growing costs associated with healthcare and pharmacy needs.

Session details:

October 29 from 3:50-4:30

Pharmacy/healthcare cost impact on EBITDA: providing solutions to CFOs

The data is clear: 96% of CFOs/CEOs are concerned about long-term cost implications of pharmacy. In this session, we'll discuss how employers can break the cycle of broker/vendor/HR dysfunction and control pharmacy spend by limiting the influence of PBMs. Be sure to check it out for insights on controlling these rapidly rising costs.

Speakers:

Todd Grove, Vice President, Private Equity, Quantum Health

Josh Bellamy, CEO, Health Strategy

Chris Kim, Chief People Officer, Cision